Immune Modulation Therapy in CHF

RS Warraich, J Young, F Sestier, S Mcree, MH Yacoub: the Prognostic Impact of Immunoglobulin G3 Reactivity in Heart Failure: A Substudy of Vasogen’s Immune Modulation Therapy in Patients with Chronic Heart Failure. J Card Fail.2003; 9(5) Supplement, page S60 (Abstracts from the 7th Annual Scientific Meeting).

Expected Versus Observed Survival in 3 Large Population Studies With HMG-CoA Reductase Inhibitors

Abdelouahed Naslafkih, MD, MSc,a
and François Sestier, MD, PhD, FACC

Cardiology Research, CHUM-Hôpital Notre-Dame
(Dr Naslafkih), 1560 Sherbrooke St, East, Montreal (QC)
H2L 4M1, Canada; Department of Nutrition and
Medicine
(Dr Sestier), University of Montreal, Montreal,
Quebec, Canada
http://www.mae.umontreal.ca/documents/expected.pdf

Continuer la lecture de Expected Versus Observed Survival in 3 Large Population Studies With HMG-CoA Reductase Inhibitors

A Quicker Method for Calculating Mortality Ratios Based on Survival Rates in Clinical Trials and Other Follow-up Studies

Journal of Insurance Medicine: Vol. 33, No. 4, pp. 339–348.
Abdelouahed Naslafkih, MD, MSc,a
and François Sestier, MD, PhD, FACC

University of Montreal, Montreal, Quebec, Canada (Mr
Naslafkih); Research Centre, Notre-Dame Hospital,
CHUM, and Faculty of Medicine, University of Montreal,
CP 6128 Succ. Centreville, Montreal, QC H3C 3J7,
Canada (Dr Sestier)
http://www.mae.umontreal.ca/documents/mortality.pdf

Continuer la lecture de A Quicker Method for Calculating Mortality Ratios Based on Survival Rates in Clinical Trials and Other Follow-up Studies

Mortality Analysis in Patients With Atrial Fibrillation and Implantable Permanent Pacemaker After Ablation of the Atrioventricular Node

Journal of Insurance Medicine: Vol. 34, No. 2, pp. 92–93.
Abdelouahed Naslafkih, MD, MSc,a
and Francois Sestier, MD, PhD, FACC

C.P. 6128 Succ. Centre-ville, Montreal (QC) Canada
H3C 3J7; E-mail: francois.sestier@umontreal.ca
Mortality Article 304N-6

http://www.mae.umontreal.ca/documents/mortality.pdf

ABSTRACT
Objective.—Atrial fibrillation is associated with excess mortality. This analysis was performed to determine the magnitude of the excess mortality risk.
Methods.—Life table analysis of a published study of 350 patients undergoing radiofrequency ablation of the atrioventricular node and permanent pacemaker implantation for symptomatic paroxysmal or chronic atrial fibrillation. A substantial proportion of subjects had evidence of left ventricular dysfunction.

Results.—In this cohort, compared to expected population mortality, the relative mortality
ratio was 234% and the annual excess death rate was 46 deaths/1000.

Diabetes Mellitus Related Morbidity, Risk of Hospitalization and Disability

Journal of Insurance Medicine: Vol. 35, No. 2, pp. 102–113
.Abdelouahed Naslafkih, MD, MSc
and François Sestier, MD, PhD, FACC
http://www.mae.umontreal.ca/documents/diabetes.pdf

ABSTRACT

Objective.—To investigate the rates of complications, hospitalizations and disabilities
attributable to type 1 and type 2 diabetes mellitus (DM) combined, unless otherwise noted.
Methodology.—Risk assessment of DM-related morbidity, hospitalizations and disabilities
using data from the medical literature and health statistics on the population. Continuer la lecture de Diabetes Mellitus Related Morbidity, Risk of Hospitalization and Disability